-
公开(公告)号:US20240316134A1
公开(公告)日:2024-09-26
申请号:US18573049
申请日:2023-03-29
申请人: KINJIRUSHI CO., LTD.
发明人: Ryuta Kawashima , Rui Nouchi , Isao Okunishi
CPC分类号: A61K36/31 , A61K9/0053 , A61K9/4866 , A61K31/26 , A61P25/28
摘要: A blood flow increasing agent for dorsolateral prefrontal cortex includes 6-methylsulfinylhexyl isothiocyanate.
-
公开(公告)号:US20240285721A1
公开(公告)日:2024-08-29
申请号:US18659701
申请日:2024-05-09
发明人: Tomy YESUDAS , Philip ALEX , Michael CENTOLA , Adam Joshua PAYNE
IPC分类号: A61K36/90 , A61K36/185 , A61K36/22 , A61K36/23 , A61K36/24 , A61K36/27 , A61K36/28 , A61K36/29 , A61K36/31 , A61K36/35 , A61K36/48 , A61K36/66 , A61K36/68 , A61K36/71 , A61K36/76 , A61K36/77 , A61K36/808 , A61K36/899
CPC分类号: A61K36/90 , A61K36/185 , A61K36/22 , A61K36/23 , A61K36/24 , A61K36/27 , A61K36/28 , A61K36/29 , A61K36/31 , A61K36/35 , A61K36/48 , A61K36/66 , A61K36/68 , A61K36/71 , A61K36/76 , A61K36/77 , A61K36/808 , A61K36/899
摘要: Disclosed herein are herbal formulations for relief from symptoms of skin disease. The formulations can also be combined with an active or inactive pharmaceutical ingredient, and/or a pharmaceutically acceptable excipient.
-
公开(公告)号:US12048712B2
公开(公告)日:2024-07-30
申请号:US18381558
申请日:2023-10-18
申请人: Bonafide Health, LLC
发明人: James R. Komorowski , Sarah Sylla , Devon Bernsley
IPC分类号: A61K36/00 , A61K31/235 , A61K31/7076 , A61K36/185 , A61K36/31 , A61K36/42 , A61K36/54 , A61K38/16 , A61P13/06
CPC分类号: A61K31/7076 , A61K31/235 , A61K36/185 , A61K36/31 , A61K36/42 , A61K36/54 , A61K38/168 , A61P13/06
摘要: Disclosed herein are compositions for supporting bladder health and/or treating, ameliorating, preventing, or reducing overactive bladder or the symptoms associated therewith. The compositions disclosed herein comprise a beta-adrenergic receptor agonist and at least one muscarinic receptor antagonist. Also described herein are methods utilizing the aforementioned compositions.
-
公开(公告)号:US20240216455A1
公开(公告)日:2024-07-04
申请号:US17916806
申请日:2021-07-23
申请人: ANUPAM GUPTA
发明人: ANUPAM GUPTA
CPC分类号: A61K36/31 , A61K9/0014 , A61K33/04 , A61K33/14 , A61K33/42 , A61K36/54 , A61K36/9066
摘要: The embodiments relate to a non-steroidal topical formulation comprising 10 wt % to 20 wt % of an active ingredient consisting of a combination of group I and group II component and 80 wt % to 90 wt % of inactive ingredient comprising one or more pharmaceutically acceptable excipient. The group I component maybe a plant extract obtained from Curcuma spp, Litsea spp., and Lepidium spp. and group II component may be selected from a group comprising Potassium sulfate (Kali sulphuricum), Potassium Phosphate (Kali phosphoricum), Sodium sulfate (Natrum sulphuricum, Sodium chloride (Natrum phosphoricum), Potassium Chloride (Kali muriaticum), and Sodium Phosphate (Natrum phosphoricum). The said formulation is capable of efficiently eliminating or reducing age-related osteoarthritic joint pain, inflammation and musculoskeletal diseases and provides long-term relief to the aged patients. Another preferred embodiment of the present invention relates to a method of preparing the said formulation.
-
公开(公告)号:US12005095B2
公开(公告)日:2024-06-11
申请号:US17177016
申请日:2021-02-16
发明人: Alexis Lavaud , Michael Laguerre , Simona Birtic , Anne Sylvie Fabiano Tixier , Marc Roller , Farid Chemat , Antoine Charles Bily
IPC分类号: A61K36/736 , A23L33/105 , A61K36/11 , A61K36/23 , A61K36/31 , A61K36/53 , A61K36/63 , A61K36/88 , B01D11/02
CPC分类号: A61K36/736 , A23L33/105 , A61K36/11 , A61K36/23 , A61K36/31 , A61K36/53 , A61K36/63 , A61K36/88 , B01D11/02 , B01D11/0288 , A61K2236/331
摘要: A eutectic extraction solvent for extracting plant (e.g. vegetable) and/or animal and/or prokaryotic biological material, wherein the solvent is a clear, stable and fluid mixture comprising:
(a) betaine or a hydrated form of betaine;
(b) at least one hydrogen bond donor compound selected from the group consisting of polyols and organic acids; and
(c) water
with the proviso that the eutectic extraction solvent does not contain any exogenous sugar and/or amine salt and/or anion.-
公开(公告)号:US20240122958A1
公开(公告)日:2024-04-18
申请号:US18381558
申请日:2023-10-18
申请人: Bonafide Health, LLC
发明人: James R. Komorowski , Sarah Sylla , Devon Bernsley
IPC分类号: A61K31/7076 , A61K31/235 , A61K36/185 , A61K36/31 , A61K36/42 , A61K36/54 , A61K38/16 , A61P13/06
CPC分类号: A61K31/7076 , A61K31/235 , A61K36/185 , A61K36/31 , A61K36/42 , A61K36/54 , A61K38/168 , A61P13/06
摘要: Disclosed herein are compositions for supporting bladder health and/or treating, ameliorating, preventing, or reducing overactive bladder or the symptoms associated therewith. The compositions disclosed herein comprise a beta-adrenergic receptor agonist and at least one muscarinic receptor antagonist. Also described herein are methods utilizing the aforementioned compositions.
-
公开(公告)号:US11957727B2
公开(公告)日:2024-04-16
申请号:US17395249
申请日:2021-08-05
IPC分类号: A61K36/82 , A61K31/09 , A61K31/122 , A61K31/26 , A61K31/353 , A61K36/31 , A61K36/45 , A61K36/71 , A61P25/28
CPC分类号: A61K36/82 , A61K31/09 , A61K31/122 , A61K31/26 , A61K31/353 , A61K36/31 , A61K36/45 , A61K36/71 , A61P25/28
摘要: Disclosed are means, methods, and therapeutic compositions for prevention of memory loss during situations of neuroinflammation. In one embodiment the invention teaches administration of the therapeutic combination of ingredients comprising of pterostilbene, Nigella sativa, sulforaphane, and epigallocatechin-3-gallate (EGCG) to a mammal suffering from inflammation in order to preserver memory function.
-
公开(公告)号:US11951146B2
公开(公告)日:2024-04-09
申请号:US17534292
申请日:2021-11-23
发明人: Thomas Ichim , Timothy G. Dixon , Famela Ramos , Wais Kaihani
IPC分类号: A61K36/82 , A61K31/09 , A61K31/122 , A61K31/155 , A61K31/26 , A61K31/352 , A61K36/31 , A61K36/45 , A61K36/71 , A61P31/14 , A61P37/04
CPC分类号: A61K36/82 , A61K31/09 , A61K31/122 , A61K31/155 , A61K31/26 , A61K31/352 , A61K36/31 , A61K36/45 , A61K36/71 , A61P37/04
摘要: Disclosed are means, compounds, and compositions of matter useful for stimulation of natural killer cell activity. On one embodiment a composition termed QuadraMune™ comprised of pterostilbene, Nigella sativa extract, green tea extract, and broccoli. In some embodiments the invention teaches the administration of a therapeutic combination of ingredients comprising of metformin, pterostilbene, Nigella sativa, sulforaphane, and epigallocatechin-3-gallate (EGCG) to a mammal in need of natural killer cell immune modulation. In another embodiment, the invention teaches administration of said therapeutic combination to a mammal infected with said SARS-CoV-2. In some embodiments dosage of said therapeutic combination is based on inflammatory and/or immunological parameters observed in patients with COVID-19.
-
公开(公告)号:US11938151B1
公开(公告)日:2024-03-26
申请号:US18519662
申请日:2023-11-27
IPC分类号: A61K33/242 , A61K36/31 , B82Y5/00
CPC分类号: A61K33/242 , A61K36/31 , B82Y5/00
摘要: In order to inhibit the growth of fungi, such as Madurella mycetomatis, gold nanoparticles are synthesized and capped with an extract of Reseda arabica. The gold nanoparticles capped with the extract of Reseda arabica are made by adding the extract of Reseda arabica to an aqueous sodium tetrachloroaurate (NaAuCl4) solution to reduce the sodium tetrachloroaurate and form a suspension of gold nanoparticles capped with the extract of Reseda arabica. The extract of Reseda arabica acts as a reducing and stabilizing agent while also functionalizing the surfaces of the gold nanoparticles to cap the surfaces. The suspension may be boiled, followed by removal of the gold nanoparticles capped with the extract of Reseda arabica from the suspension. To treat a Madurella mycetomatis infection, an effective dose of the gold nanoparticles capped with Reseda arabica extract may be administered to a patient in need thereof.
-
公开(公告)号:US20240091299A1
公开(公告)日:2024-03-21
申请号:US17947012
申请日:2022-09-16
申请人: The Hidden Vault LLC
发明人: Temeka Jones
IPC分类号: A61K36/9068 , A61K9/00 , A61K31/05 , A61K36/068 , A61K36/185 , A61K36/258 , A61K36/31 , A61K36/41 , A61K36/63 , A61K36/746 , A61K36/79 , A61K36/82 , A61K36/8962
CPC分类号: A61K36/9068 , A61K9/0034 , A61K31/05 , A61K36/068 , A61K36/185 , A61K36/258 , A61K36/31 , A61K36/41 , A61K36/63 , A61K36/746 , A61K36/79 , A61K36/82 , A61K36/8962
摘要: The present invention provides compositions formulated for topical administration to a penis of a person to enhance sexual responsiveness in the person, to enhance sexual performance, erection and stamina, and to increase the physical size of the penis, where the compositions comprise active components from herbal or plant origin including maca, tongkat ali, cordyceps, ginseng, fructus schisandrae. morinda root, rhodiola, rosea cordyceps sinensis, ginger, jasmine, sandalwood, leeks, camellia seed, jojoba oil and cannabidiol. The preferred composition is in the form of a massage oil, to be applied topically to the skin of the penis.
-
-
-
-
-
-
-
-
-